# NextGen Jane

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nextgen-jane

- Industry: Software
- Headquarters: Oakland, US
- Website: www.nextgenjane.com
- Total disclosed funding: $8.8M
- Latest round: Series A (Mar 19, 2019)
- Investors on record: 4

## About

NextGen Jane, Inc. is focused on women's reproductive health, offering innovative solutions that harness genomic analysis of menstrual fluid samples to provide insights into menstrual health and reproductive issues.NextGen Jane, Inc. was founded in 2014 and operates from Oakland, US. It specializes in women's reproductive health through the collection and analysis of menstrual fluid. The company has completed a total of 3 deals, with its most recent deal occurring on September 20, 2023. NextGen Jane raised USD 7.02 mn in Series A funding, which represents the total amount raised to date, now valued at USD 31.10 mn. Ridhi Tariyal serves as both CEO and Founder of the company.NextGen Jane specializes in innovative health solutions focused on women's reproductive health, primarily through the collection and analysis of menstrual fluid samples. Their core offering is a patented collection kit designed for home use, which includes organic cotton tampons specifically for gathering samples. This allows users to safely send their samples to the company for genomic analysis, enabling the connection between menstrual cycle data and broader health outcomes, including reproductive issues such as endometriosis. The target audience consists of women interested in understanding their menstrual health better, with a focus on the U.S. market, although potential expansion into other regions may be considered in the future. Through their comprehensive survey and sample analysis, NextGen Jane aims to empower individuals with insights that promote proactive health management.NextGen Jane generates revenue through a subscription-based model targeting consumers who participate in their longitudinal study of menstrual health. Clients typically enroll in the program by signing up for a subscription that includes the collection kit and access to ongoing insights derived from their genomic data. Transactions are structured around these subscriptions, allowing customers to engage continuously with the company and receive regular updates about their health insights. The pricing structure is designed to facilitate accessibility for individuals seeking to gain a deeper understanding of their reproductive health. By focusing on direct-to-consumer sales, NextGen Jane reinforces its commitment to empowering women with the knowledge they need while fostering a community aimed at advancing the science of gynecological health.In September 2023, NextGen Jane, Inc. raised USD 7.02 mn in Series A funding as part of a larger USD 7.77 mn seed funding effort. The company plans to utilize this funding to develop new products aimed at enhancing women's health solutions and to expand its reach into additional markets. Specific targeted regions for expansion remain under consideration, with potential plans to launch new products by late 2024. This strategy aligns with their mission to broaden access to reproductive health insights.

## Funding rounds

- Series A, Mar 19, 2019, $8.8M — Access Industries, Viking Global Investors, Material Impact Fund, Liminal Ventures

## Investors

- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series A
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series A
- Material Impact Fund (https://capitalatlas.ai/funds/material-impact-fund) — Series A
- Liminal Ventures — Series A